Kokoona zeylanica
Kokoona zeylanica · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Kokoona zeylanica is a botanical species that has garnered significant scientific interest due to its potential therapeutic properties. Researchers have focused on the plant's stem, specifically utilizing aqueous stem bark extracts for medicinal study. A key chemical constituent identified within this plant is demethylzeylasterone, which plays a crucial role in its biological activity. Current studies highlight its promising anticancer activities, particularly in addressing conditions such as breast cancer. Furthermore, the plant shows potential in the management of metabolic disorders like diabetes mellitus.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Celastraceae
- Distribution
- Not available
- Plant Parts
- Stem
Classification
Taxonomy
Kokoona zeylanica is a fascinating botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the plant is specifically classified under the class Equisetopsida. It further falls into the order Celastrales, showcasing its unique evolutionary lineage. The species is a prominent member of the Celastraceae family, which defines its many biological characteristics. Finally, it is categorized under the genus Kokoona, placing it within a distinct group of related plants.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Celastrales |
| Family | Celastraceae |
| Genus | Kokoona |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Kokoona zeylanica is a specialized plant species primarily found within the tropical regions of Asia. Its natural distribution is concentrated heavily throughout the Indian Subcontinent, where it thrives in specific ecological niches. Within this vast geographic range, India serves as a key habitat for the species to flourish. Furthermore, the plant also maintains a significant presence across the island nation of Sri Lanka. These interconnected locations highlight the specific environmental requirements necessary for the survival of this tropical flora.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Kokoona zeylanica is a self-supporting species characterized by its distinct tree-like growth form. This robust structure allows the plant to stand independently as it matures within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Kokoona zeylanica contains a specialized 6-oxophenolic triterpenoid known as demethylzeylasterone that exhibits significant anticancer potential. Research indicates that this compound acts as a potent catalytic inhibitor of the enzyme topoisomerase IIalpha. By targeting this enzyme, demethylzeylasterone demonstrates the ability to selectively inhibit the growth of the MCF-7 breast cancer cell line. Interestingly, this inhibitory effect appears specific, as it does not affect non-small cell lung cancer or CNS glioma cell lines. This discovery marks the first reported instance of topoisomerase II inhibitory activity within a celastroloid.
Compounds
Kokoona zeylanica is the botanical source of demethylzeylasterone, a significant 6-oxophenolic triterpenoid. Research indicates that this specific compound acts as a potent catalytic inhibitor of the enzyme topoisomerase IIalpha. In laboratory evaluations, demethylzeylasterone demonstrated a specialized ability to inhibit the growth of the MCF-7 breast cancer cell line. Interestingly, this inhibitory effect appears selective, as it does not impact non-small cell lung cancer or CNS glioma cell lines. This discovery marks the first reported instance of topoisomerase II inhibitory activity within the celastroloid family.
Conditions
Kokoona zeylanica demonstrates significant medicinal potential through its ability to treat diabetes mellitus and improve glucose tolerance. Research indicates that aqueous stem bark extracts of this plant possess potent acute antihyperglycaemic activity in alloxan induced diabetic rats. Furthermore, the plant contains demethylzeylasterone, a triterpenoid that can effectively treat breast cancer by selectively inhibiting the growth of MCF-7 cell lines. These combined properties highlight the plant's diverse therapeutic applications in managing both metabolic and oncological conditions. Through these biological mechanisms, Kokoona zeylanica serves as a valuable resource for treating various systemic ailments.
Preparations
Kokoona zeylanica is prepared as aqueous stem bark extracts for use in medicinal studies. This specific preparation method is utilized to evaluate its efficacy in treating diabetes mellitus. Within the research context, these aqueous extracts are administered to alloxan-induced diabetic rats to test their antihyperglycaemic properties. The study demonstrates that this particular formulation of the plant's stem bark provides significant improvements in glucose tolerance. Consequently, the aqueous stem bark extract of Kokoona zeylanica is identified as having potent acute antihyperglycaemic activity.
Parts used
Kokoona zeylanica is a significant medicinal plant identified in studies focusing on traditional Ayurvedic treatments for diabetes mellitus in Sri Lanka. Researchers specifically utilized the aqueous stem extracts of this Celastraceae species to investigate its potential therapeutic effects. During controlled experiments involving alloxan-induced diabetic rats, the plant's stem components were tested across various dosage levels. The findings demonstrated that Kokoona zeylanica possesses potent acute antihyperglycaemic activity, showing a statistically significant improvement in glucose tolerance. This research underscores the medicinal importance of the plant's stem in managing blood sugar levels through natural means.